NCT03374488 2025-08-22Pembrolizumab + Epacadostat vs Pembrolizumab + Placebo in Recurrent or Progressive Metastatic Urothelial CarcinomaIncyte CorporationPhase 3 Completed84 enrolled 13 charts
NCT03361228 2020-05-21A Study to Evaluate the Safety, Tolerability, and Antitumor Activity of INCB001158 Plus Epacadostat, With or Without Pembrolizumab, in Advanced Solid TumorsIncyte CorporationPhase 1/2 Terminated5 enrolled 4 charts